Cell death assays by Propidium Iodide labeling DIV 1 neurons were incubated for the indicated period of time either with or without AICAR. For glutamate positive control, DIV 14 neurons were treated with glutamate (100 μM) for 1 hr before 4 hrs of treatment free incubation. Following treatment, Propidium Iodide (1 μg/mL) and Hoechst (0.5 ng/mL) were co-administered for 20 minutes during live cell incubation.
Live imaging
Dissociated E18 primary hippocampal neurons were transfected with a GFP tagged version of the Akt pleckstrin homology (PH) (S4) domain using lipofectamine 2000 (Invitrogen) and plated onto coverslips. 20 hr after plating, the coverslip was transferred to a live imaging chamber containing 500 μl ACSF under temperature control (37 o C). Images of GFP fluorescence were acquired at 10 min intervals for a total period of 50 min. Adjustment was made each time before imaging to ensure sharp focus. AICAR dissolved in ACSF was supplemented to the chamber after the second imaging, and the same amount of ACSF was given in the control coverslips.
Site directed mutagenesis and GST fusion protein preparation.
Full-length mouse KLC2 cDNA was amplified by PCR and subcloned into pGEX-KG vector. KLC2 S539A, S575A, and double mutants were generated using QuickChange Site-directed Mutagenesis kit (Strategene) and verified by DNA sequencing. Recombinant GST fusion proteins of KLC2 WT and mutants were expressed in E. coli BL21 and purified on glutathione-Sepharose 4B beads (Pharmacia) according to manufacturer's instructions.
In vitro kinase assays.
To evaluate whether PI3K and/or KLC could be a potential AMPK substrate, we scanned the sequences of both PI3K and KLC with AMPK consensus phosphorylation sites ( fig. S17 , B) (S5). We identified two sections of evolutionarily conserved sequences nearly identical to the AMPK phosphorylation consensus sequence in both isoforms of KLC. Of the two KLC isoforms, KLC 1 knockout mice showed no defects in neurite formation or axon guidance (S6), whereas KLC1/2 double knockout revealed defects in axon growth (S7) . In addition, KLC2 has been shown to carry cargos in a phosphorylation-dependent manner (S8), indicating KLC2 as a potential AMPK target. To explore this possibility, recombinant GST-KLC2 fusion proteins were incubated with purified AMPK proteins (Millipore) in kinase buffer (50 mM Tris, pH 7.5, 10 mM MgCl2, 1 mM β-glycerophosphate and 100 μM ATP) in the presence of 10 μCi γ-32P-ATP at 37°C for 30 min, followed by SDS-PAGE and autoradiography.
Identification of phosphorylation sites by mass spectrometry HEK293 cells were transfected with pCDNA3-myc-KLC2 using Fugene 6 (Roche). Cell lysates were prepared in lysis buffer containing 10 mM HEPES (pH 7.0), 150 mM NaCl, 1% NP-40, 1 mM EDTA, 50 mM NaF, 10 mM β-glycero-phosphate,10 nM calyculin A, 1 mM Na3VO4 and protease inhibitors, and subjected for immunoprecipitation with antimyc antibodies. Coomassie brilliant blue-stained SDS-PAGE gel bands containing myc-KLC2 were excised and subjected to in-gel digestion and reversed-phase microcapillary LC/MS/MS using a LTQ 2D linear ion trap mass spectrometer (Thermo Scientific) at the Beth Israel Deaconess Medical Center Mass Spectrometry Core facility. MS/MS spectra were searched against the reversed Swiss-Prot protein database using Sequest alogrism (Proteomics Browser, ThermoScientific) with differential modifications for Ser/Thr/Tyr phosphorylation (+79.97).
Organotypic cortical slice culture
Coronal embryonic brain slices (300 μm) were prepared from CD-1 pregnant mice (E14) as previously described (Liu et al., 2008) . The slices were placed onto Millicell-CM culture inserts (Millipore, Bedford) in 6-well culture trays (Corning, Inc., Corning) with neuronal base medium containing 1% N2, 2% B27, 1% Glutamax, 2.5 % HEPES buffer (1M) and 1% Pen/Strep (GIBCO) and then incubated at 37°C in 5% CO 2 incubator. After infection with CAG-GFP retrovirus (1.0X10 6 c.f.u. /ml) (S9) for 12 h, the slices were maintained in the presence or absence of AICAR (2 mM) for 72 hrs. For AMPK-KD rescuing study, the embryonic brain (E15.5) was electroporated in utero with Tα-1 venus plasmid combined with or without KD as previously described. The concentration of plasmid was adjusted to 1μg/μl with TE buffer and a total volume of 1-2 μl plasmid solution with fast green (0.3%) was injected into the later cerebral ventricle. Electroporation parameters: 50 V, 50 ms X 4 with 950 ms intervals. After electroporation, the embryo was decapitated and the brain was removed for slices section as described above. Slices were first cultured for 24 hrs and then cultured for 48 hrs with the presence or absence of 2mM AICAR. The slices were fixed in 4% PFA and then cryoprotectively resectioned into 60 μm for Z-stack confocal scanning (1-2 μm, 10-15 sections). Scanned optic images of cortical EGFP positive pyramidal neurons that were identified by their morphology and apical dendrite were projected into single planes. The outline of the pyramid neurons were imprinted into a separate layer using Adobe Photoshop and their axonal length, total dendritic length and the number of dendrite branches were measured using AxioVision.
Image acquisition, quantification and analysis
Neuron morphology and protein localization was examined analyzed with a Zeiss inverted microscope Axiovert 200 equipped with epifluorescence and differential interference contrast (DIC) optics. Images of neurons were taken with a Zeiss Axiocam camera and analyzed using Image-J software. Neuronal polarity was assessed by determining the percentage of polarized cells within 10 or more images taken at 20x magnification. A neuron was considered polarized if the longest neurite was at least twice as long as any sister neurite. For morphological measurement of both treated and non-treated populations, the longest neurite from each neuron was considered the axon while all remaining sister neurites were measured as dendrites (non-axonal minor neurites) Total growth refers to sum length of all processes. Axon specific growth was obtained by subtracting average dendritic length from the total axon length (longest process) of the same cell. p85/p-Akt tip enrichment was determined by the ratio of the immunofluorescence intensity at the tip (7 μm from the end of the process) of the longest neurite over the signal intensity at the middle (total process length was divided into equal thirds, middle third was used to obtain ratio) of the same process. For normalization of pAkt tip fluorescence, pAkt signal intensity was normalized to tip area as indicated by EGFP, after which the resulting value for AICAR treated normalized tip pAkt intensity was then normalized to the control value. For each construct transfection or pharmacological treatment, at least three independent experiments involving multiple (3-30) coverslips were performed. All values are reported as mean ± SEM. Statistical analysis was performed using the two-population student's t test, or analysis of variance with Tukey post-test.
Supporting Figure S1 Neurons were treated with AICAR 6 hrs after plating for 2 hrs, 15 hrs or 40 hrs. 2 wk neuron samples were treated for 15 hrs before 2 wks of treatment free incubation. Cells were simultaneously labeled with Hoechst (to indicate total cell number) and Propidium Iodide (P.I., to indicate dying cells) prior to fixation and imaging. 2 wk old hippocampal neurons treated with glutamate (100 μM) were used as a positive control for cell death. Arrows indicate P.I. positive cells. Scale Bar = 20 μm. (B and C) AICAR treatment of various durations did not affect cell viability, while glutamate treatment of 2 wk-old neurons produced a significant increase in P.I. labeling and a decrease in total cell count as compared to control. n = 1026. *p < 0.05, two population student's t-test. (D) 2 wk neurons were treated with AICAR 6 hrs after plating for a duration of 15 hrs before incubation with culture medium for 2 wks. Western analysis showed that none of the tested treatment paradigms produced a decrease in GAPDH levels as compared to control cells, indicating a lack of cell loss by AICAR treatment. Scale bar = 20 μm. C and D) AICAR treatment showed no effect on polarization and axon length. n = 22; *p < 0.05, two-population student's t-test. Scale bar = 20 μm. 
